# Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

> **NCT00276445** · PHASE4 · TERMINATED · sponsor: **Meiji University of Oriental Medicine** · enrollment: 60 (—)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** beta-1,3-glucan

## Key facts

- **NCT ID:** NCT00276445
- **Lead sponsor:** Meiji University of Oriental Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276445, "Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00276445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*